Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mammographic Density and the Risk of Tumor Recurrence in Asian Women: a Case-control Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02771665
Recruitment Status : Completed
First Posted : May 13, 2016
Last Update Posted : May 13, 2016
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital

Brief Summary:
To evaluate the influence of mammographic breast density at diagnosis on the risk of cancer recurrence and survival outcome in patients with invasive breast cancer after surgery

Condition or disease Intervention/treatment
Case Control Study Other: Mammographic breast density at diagnosis

Layout table for study information
Study Type : Observational
Actual Enrollment : 300 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Mammographic Density and the Risk of Tumor Recurrence in Asian Women: a Case-control Study
Study Start Date : March 2014
Actual Primary Completion Date : March 2015
Actual Study Completion Date : March 2015

Group/Cohort Intervention/treatment
Breast cancer women with known recurrences
Breast cancer women with known recurrences (locoregional recurrence and distant metastasis)
Other: Mammographic breast density at diagnosis
Mammographic breast density at diagnosis

Breast cancer women without recurrences
Breast cancer women without recurrences
Other: Mammographic breast density at diagnosis
Mammographic breast density at diagnosis




Primary Outcome Measures :
  1. Hazard ratios for recurrence [ Time Frame: 2004 to 2009 ]

Secondary Outcome Measures :
  1. Hazard ratios for death [ Time Frame: 2004 to 2009 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women diagnosed with invasive breast cancer who had undergone surgery between 2004 and 2009
Criteria

Inclusion Criteria:

  • Women diagnosed with invasive breast cancer between 2004 and 2009 who had undergone surgery and had the mammographic breast density ascertained before, or at, diagnosis.

Exclusion Criteria:

  • Women diagnosed with invasive breast cancer between 2004 and 2009 who had not undergone surgery or who had no mammographic breast density ascertained before, or at, diagnosis.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02771665


Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Jenny Ling-Yu Chen, MD National Taiwan University Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT02771665    
Other Study ID Numbers: 201401068RIND
First Posted: May 13, 2016    Key Record Dates
Last Update Posted: May 13, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Recurrence
Disease Attributes
Pathologic Processes